Torren Management
INBX icon

Torren Management’s Inhibrx INBX Stock Holding History

Torren Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.5K Sell
65
-45
-41% -$4.49K ﹤0.01% 283
2026
Q2 		$10.4K Hold
110
– – 0.01% 208
2026
Q1 		$7.4K Hold
110
– – ﹤0.01% 242
2025
Q4 		$8.69K Buy
+110
New +$7.5K ﹤0.01% 796

Other funds holding INBX

Sanofi
Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Empirical Wealth Management
Empirical Wealth Management Seattle, Washington $7.38B AUM 22.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Torren Management's INBX Position: Q3 2026 in Review

Torren Management reduced its Inhibrx (INBX) stake by 41% in Q3 2026, selling an estimated $4.49K and leaving 65 shares worth $6.5K. The position accounts for ﹤0.01% of the portfolio, ranked #283.

Torren Management first reported a position in INBX in Q4 2025 and has held it in 4 quarters since. The position peaked at $10.4K in Q2 2026. 60 funds tracked by Wall St. Rank hold INBX as of Q3 2026.

  • Torren Management held 65 shares of Inhibrx worth $6.5K as of Q3 2026.
  • Torren Management sold 45 Inhibrx shares in Q3 2026, an estimated $4.49K.
  • Inhibrx made up ﹤0.01% of Torren Management's portfolio in Q3 2026, its #283 holding.
  • Torren Management first reported a position in Inhibrx in Q4 2025 and has held it in 4 quarters since.
  • Torren Management's Inhibrx position peaked at $10.4K in Q2 2026.
  • 60 funds tracked by Wall St. Rank held Inhibrx as of Q3 2026.

Based on Torren Management's 13F filing for Q3 2026, filed 29 Oct 2026.